May 14 |
Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses
|
May 14 |
Aptose Reports Results for the First Quarter 2024
|
May 6 |
Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024
|
Apr 5 |
What Makes Aptose Biosciences (APTO) a New Buy Stock
|
Mar 27 |
Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2023 Earnings Call Transcript
|
Mar 27 |
Aptose Biosciences Inc. (APTO) Q4 2023 Earnings Call Transcript
|
Mar 26 |
Aptose Biosciences GAAP EPS of -$7.58 beats by $0.40
|
Mar 26 |
Aptose Reports Results for the Fourth Quarter and Full Year 2023
|
Mar 25 |
Aptose Biosciences Q4 2023 Earnings Preview
|
Mar 18 |
Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
|